Charles R. Ashby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles R. Ashby has a total of 413 co-authors. Here are the top co-authors by number of shared publications:
- Amit Kumar Tiwari
Department of Pharmaceutical Sciences, College of Pharmacy University of Arkansas for Medical Sciences Little Rock Arkansas USA
19 shared publications - Zhe-Sheng Chen
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, New York, USA
14 shared publications - Junsheng Zhang
Sun Yat-sen University Cancer Center 1 Department of Breast Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer Guangzhou, China
11 shared publications - Lu Yang
Department of Radiation Oncology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
11 shared publications - Ning Li
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
11 shared publications - Rongrong Li
Sun Yat-sen University Cancer Center 3 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer Guangzhou, China
11 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Data from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Fasting-mimicking diets (FMD) have been reported to increase the antitumor efficacy in preclinical studies in various cancers. FMD can affect the tumor microenvironment (TME), and elucidating the mechanisms and cells mediating the effects of FMD may uncover combination treatment strategies. Here, we performed single-cell transcriptomic sequencing to characterize the TME changes induced by FMD intervention in a mouse model of spontaneous breast cancer. The sequencing data indicated that FMD suppressed tumor cell stemness, promoted apoptosis, and increased the infiltration of innate and adaptive immune cells, especially natural killer (NK) cells and effector CD8+ T cells. Importantly, FMD induced phenotypic reprogramming of cancer-associated fibroblasts (CAF), leading to a decrease in the immunosuppressive inflammatory CAF (iCAF) subset. Mechanistically, FMD decreased platelet-derived growth factor C (PDGFC) secretion in tumor cells by reducing glucose levels and inhibiting glycolysis to reprogram CAFs. PDGFC increased the activation of the JAK–STAT3 pathway, which induced iCAF differentiation. Combining FMD with PDGF receptor (PDGFR) inhibitors increased the efficacy of anti–PD-L1 immunotherapy in vivo. Overall, this study reveals a mechanism of metabolic–immune rewiring through which FMD suppresses tumor progression, providing preliminary evidence for the potential of combination FMD-based strategies in breast cancer treatment. Significance:Fasting-mimicking diet blocks breast cancer cell-induced generation of immunosuppressive fibroblasts, thereby facilitating tumor infiltration of immune cells and stimulating antitumor immunity to sensitize breast cancer to immunotherapy.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Fasting-mimicking diets (FMD) have been reported to increase the antitumor efficacy in preclinical studies in various cancers. FMD can affect the tumor microenvironment (TME), and elucidating the mechanisms and cells mediating the effects of FMD may uncover combination treatment strategies. Here, we performed single-cell transcriptomic sequencing to characterize the TME changes induced by FMD intervention in a mouse model of spontaneous breast cancer. The sequencing data indicated that FMD suppressed tumor cell stemness, promoted apoptosis, and increased the infiltration of innate and adaptive immune cells, especially natural killer (NK) cells and effector CD8+ T cells. Importantly, FMD induced phenotypic reprogramming of cancer-associated fibroblasts (CAF), leading to a decrease in the immunosuppressive inflammatory CAF (iCAF) subset. Mechanistically, FMD decreased platelet-derived growth factor C (PDGFC) secretion in tumor cells by reducing glucose levels and inhibiting glycolysis to reprogram CAFs. PDGFC increased the activation of the JAK–STAT3 pathway, which induced iCAF differentiation. Combining FMD with PDGF receptor (PDGFR) inhibitors increased the efficacy of anti–PD-L1 immunotherapy in vivo. Overall, this study reveals a mechanism of metabolic–immune rewiring through which FMD suppresses tumor progression, providing preliminary evidence for the potential of combination FMD-based strategies in breast cancer treatment. Significance:Fasting-mimicking diet blocks breast cancer cell-induced generation of immunosuppressive fibroblasts, thereby facilitating tumor infiltration of immune cells and stimulating antitumor immunity to sensitize breast cancer to immunotherapy.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD inhibits breast tumor growth in both syngeneic and spontaneous mouse models.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD inhibits breast tumor growth in both syngeneic and spontaneous mouse models.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD increases lymphoid cell infiltration in breast tumor.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD increases lymphoid cell infiltration in breast tumor.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD decreases the expression of immune checkpoints and increases immune cell infiltration.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD decreases the expression of immune checkpoints and increases immune cell infiltration.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD reprograms cancer-associated fibroblasts (CAFs).
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD reprograms cancer-associated fibroblasts (CAFs).
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Primer sequences for RT-qPCR detection.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Primer sequences for RT-qPCR detection.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD combined with PDGFR inhibitors increases immunotherapy efficacy in breast cancer.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
FMD combined with PDGFR inhibitors increases immunotherapy efficacy in breast cancer.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Antibodies used in this study.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Antibodies used in this study.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Flow cytometry gating strategies for NK cand T cells.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Flow cytometry gating strategies for NK cand T cells.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Sequences of the siRNAs and shRNAs.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer
Sequences of the siRNAs and shRNAs.